James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 3,450 shares at $48.26 ($166K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Seasonal sale ($166k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRSP | SELL | 2026-09-24 | $626K | — | Filing → |
| CRSP | SELL | 2026-03-24 | $149K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |